BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19429855)

  • 1. Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.
    Feo F; Frau M; Tomasi ML; Brozzetti S; Pascale RM
    Exp Biol Med (Maywood); 2009 Jul; 234(7):726-36. PubMed ID: 19429855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
    Calvisi DF; Pinna F; Ladu S; Pellegrino R; Muroni MR; Simile MM; Frau M; Tomasi ML; De Miglio MR; Seddaiu MA; Daino L; Sanna V; Feo F; Pascale RM
    Carcinogenesis; 2008 Aug; 29(8):1639-47. PubMed ID: 18579559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of major genes predisposing to hepatocellular carcinoma with genes encoding signal transduction pathways influences tumor phenotype and prognosis.
    Feo F; Frau M; Pascale RM
    World J Gastroenterol; 2008 Nov; 14(43):6601-15. PubMed ID: 19034960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
    Frau M; Biasi F; Feo F; Pascale RM
    Mol Aspects Med; 2010 Apr; 31(2):179-93. PubMed ID: 20176048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma.
    Calvisi DF; Pinna F; Meloni F; Ladu S; Pellegrino R; Sini M; Daino L; Simile MM; De Miglio MR; Virdis P; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
    Cancer Res; 2008 Jun; 68(11):4192-200. PubMed ID: 18519678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control.
    Calvisi DF; Pinna F; Pellegrino R; Sanna V; Sini M; Daino L; Simile MM; De Miglio MR; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
    Int J Cancer; 2008 Nov; 123(9):2057-64. PubMed ID: 18697198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
    Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
    Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.
    Calvisi DF; Pinna F; Ladu S; Pellegrino R; Simile MM; Frau M; De Miglio MR; Tomasi ML; Sanna V; Muroni MR; Feo F; Pascale RM
    Gut; 2009 May; 58(5):679-87. PubMed ID: 19136513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
    Pascale RM; Simile MM; Calvisi DF; Frau M; Muroni MR; Seddaiu MA; Daino L; Muntoni MD; De Miglio MR; Thorgeirsson SS; Feo F
    Hepatology; 2005 Dec; 42(6):1310-9. PubMed ID: 16317707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
    Frau M; Tomasi ML; Simile MM; Demartis MI; Salis F; Latte G; Calvisi DF; Seddaiu MA; Daino L; Feo CF; Brozzetti S; Solinas G; Yamashita S; Ushijima T; Feo F; Pascale RM
    Hepatology; 2012 Jul; 56(1):165-75. PubMed ID: 22318685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis of hepatocellular carcinoma.
    Wong CM; Ng IO
    Liver Int; 2008 Feb; 28(2):160-74. PubMed ID: 18069974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping a sex hormone-sensitive gene determining female resistance to liver carcinogenesis in a congenic F344.BN-Hcs4 rat.
    De Miglio MR; Virdis P; Calvisi DF; Frau M; Muroni MR; Simile MM; Daino L; Careddu GM; Sanna-Passino E; Pascale RM; Feo F
    Cancer Res; 2006 Nov; 66(21):10384-90. PubMed ID: 17079458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies.
    Feo F; Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi D
    Crit Rev Oncog; 2000; 11(1):19-62. PubMed ID: 10795626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell brain: insight into hepatocarcinogenesis.
    Chen Y; Kong Q
    Med Hypotheses; 2006; 67(1):44-52. PubMed ID: 16600524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomics and signaling pathways in hepatocellular carcinoma.
    Villanueva A; Newell P; Chiang DY; Friedman SL; Llovet JM
    Semin Liver Dis; 2007 Feb; 27(1):55-76. PubMed ID: 17295177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of hepatocellular carcinoma and molecular therapies.
    Mínguez B; Tovar V; Chiang D; Villanueva A; Llovet JM
    Curr Opin Gastroenterol; 2009 May; 25(3):186-94. PubMed ID: 19387255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease.
    Calvisi DF; Pinna F; Ladu S; Muroni MR; Frau M; Demartis I; Tomasi ML; Sini M; Simile MM; Seddaiu MA; Feo F; Pascale RM
    Int J Cancer; 2010 Mar; 126(5):1275-81. PubMed ID: 19533683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.